BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26096891)

  • 41. Inducible expression and pharmacology of the human excitatory amino acid transporter 2 subtype of L-glutamate transporter.
    Dunlop J; Lou Z; Zhang Y; McIlvain HB
    Br J Pharmacol; 1999 Dec; 128(7):1485-90. PubMed ID: 10602327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Yes-associated protein regulates glutamate homeostasis through promoting the expression of excitatory amino acid transporter-2 in astrocytes via β-catenin signaling.
    Xu X; Wang J; Du S; Shen X; Lian J; Zhou J; Wang M; Feng W; Lv Z; Zhu J; Jin L; Sun H; Wu L; Wang X; Qiu H; Wang W; Teng H; Wang Y; Huang Z
    Glia; 2023 May; 71(5):1197-1216. PubMed ID: 36617748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter.
    Yatomi Y; Tanaka R; Shimura H; Miyamoto N; Yamashiro K; Takanashi M; Urabe T; Hattori N
    Neuroscience; 2013 Aug; 244():113-21. PubMed ID: 23602887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype.
    Robinson MB
    Neurochem Int; 1998 Dec; 33(6):479-91. PubMed ID: 10098717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis.
    Münch C; Ebstein M; Seefried U; Zhu B; Stamm S; Landwehrmeyer GB; Ludolph AC; Schwalenstöcker B; Meyer T
    J Neurochem; 2002 Aug; 82(3):594-603. PubMed ID: 12153483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leucine 434 is essential for docosahexaenoic acid-induced augmentation of L-glutamate transporter current.
    Takahashi K; Chen L; Sayama M; Wu M; Hayashi MK; Irie T; Ohwada T; Sato K
    J Biol Chem; 2023 Jan; 299(1):102793. PubMed ID: 36509140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury.
    Verma R; Mishra V; Sasmal D; Raghubir R
    Eur J Pharmacol; 2010 Jul; 638(1-3):65-71. PubMed ID: 20423712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-regulation of astrocyte excitatory amino acid transporter 2 alleviates central sensitization in a rat model of chronic migraine.
    Zhou X; Liang J; Wang J; Fei Z; Qin G; Zhang D; Zhou J; Chen L
    J Neurochem; 2020 Nov; 155(4):370-389. PubMed ID: 31872442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats.
    Zaitsev AV; Malkin SL; Postnikova TY; Smolensky IV; Zubareva OE; Romanova IV; Zakharova MV; Karyakin VB; Zavyalov V
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.
    Rothstein JD; Patel S; Regan MR; Haenggeli C; Huang YH; Bergles DE; Jin L; Dykes Hoberg M; Vidensky S; Chung DS; Toan SV; Bruijn LI; Su ZZ; Gupta P; Fisher PB
    Nature; 2005 Jan; 433(7021):73-7. PubMed ID: 15635412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.
    Yi JH; Hazell AS
    Neurochem Int; 2006 Apr; 48(5):394-403. PubMed ID: 16473439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subcellular localization of the glutamate transporters GLAST and GLT at the neuromuscular junction in rodents.
    Rinholm JE; Slettaløkken G; Marcaggi P; Skare Ø; Storm-Mathisen J; Bergersen LH
    Neuroscience; 2007 Mar; 145(2):579-91. PubMed ID: 17289278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-Dependent Alterations in the Interactions of NF-κB and N-myc with GLT-1/EAAT2 Promoter in the Pericontusional Cortex of Mice Subjected to Traumatic Brain Injury.
    Gupta RK; Prasad S
    Mol Neurobiol; 2016 Jul; 53(5):3377-3388. PubMed ID: 26081154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered expression of the glutamate transporter EAAT2b in neurological disease.
    Maragakis NJ; Dykes-Hoberg M; Rothstein JD
    Ann Neurol; 2004 Apr; 55(4):469-77. PubMed ID: 15048885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis.
    Sullivan R; Rauen T; Fischer F; Wiessner M; Grewer C; Bicho A; Pow DV
    Glia; 2004 Jan; 45(2):155-69. PubMed ID: 14730709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Astrocytic transcription factor REST upregulates glutamate transporter EAAT2, protecting dopaminergic neurons from manganese-induced excitotoxicity.
    Pajarillo E; Digman A; Nyarko-Danquah I; Son DS; Soliman KFA; Aschner M; Lee E
    J Biol Chem; 2021 Dec; 297(6):101372. PubMed ID: 34756885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line.
    Legay V; Deleage C; Beaulieux F; Giraudon P; Aymard M; Lina B
    Eur J Neurosci; 2003 May; 17(9):1820-8. PubMed ID: 12752781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.
    Selkirk JV; Nottebaum LM; Vana AM; Verge GM; Mackay KB; Stiefel TH; Naeve GS; Pomeroy JE; Petroski RE; Moyer J; Dunlop J; Foster AC
    Eur J Neurosci; 2005 Jun; 21(12):3217-28. PubMed ID: 16026460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.
    Tian G; Kong Q; Lai L; Ray-Chaudhury A; Lin CL
    J Neurochem; 2010 May; 113(4):978-89. PubMed ID: 20193040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.